Mechanisms of relapse in B-cell malignancies, including B-ALL, have been extensively studied, with CD19 escape identified as a major cause, along with the lack of CAR T-cell persistence (6–8). Here, CD19 is linked to precursor B-cell acute lymphoblastic leukemia.